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Abstract
Microdeletions in the AZF region of the Y chromosome are among the most frequent genetic causes of male infertility,
although the specific role of the genes located in this region is not fully understood. AZFa and AZFb deletions impair
spermatogenesis since no spermatozoa are found in the testis. Deletions of the AZFc region, despite being the most
frequent in azoospermic patients, do not correlate with spermatogenic failure. Therefore, the aim of this work was to
develop a screening method to ascertain the presence of the main spermatogenesis candidate genes located in the AZFc
region in the light of the identification of those responsible for spermatogenic failure. DAZ, CDY, BPY2, PRY, GOLGA2LY and
CSGP4LY genes were selected on the basis of their location in the AZFc region, testis-only expression, and confirmed or
predicted protein codification. AMEL and SRY were used as amplification controls. The identification of Real Time PCR
products was performed by High Resolution Melting analysis with SYTO 9 as intercalating dye. The herein described method
allows a rapid, simple, low-cost, high-throughput screening for deletions of the main AZFc genes in patients with
spermatogenic failure. This provides a strategy that would accelerate the identification of spermatogenesis candidate genes
in larger populations of patients with non-obstructive idiopathic azoospermia.
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Introduction
Infertility affects about 15% of the couples trying to conceive. In
half of the cases, the underlying cause can be partially or totally
attributed to the male partner, and 10–15% of the cases could be
due to genetic abnormalities [1]. For many years, microdeletions
in the euchromatic region of the Y chromosome have been linked
to spermatogenic failure, as cytogenetic studies associated a
deletion on its long arm (Yq) to azoospermia [2]. The azoospermia
factor region (AZF) and its sub-regions AZFa, AZFb and AZFc are
the main targets for molecular diagnosis [3,4]. These AZF loci are
routinely screened for possible microdeletions using sequence
tagged sites (STSs), as recommended by the European Academy of
Andrology (EAA) [5]. This diagnostic testing of Yq microdeletions
is generally performed by PCR amplification of selected STSs on
the Y chromosome. The precise sequencing and mapping of the
male-specific region of the Y chromosome clarified that many
STSs used in initial screening were polymorphic, ambiguous,
heterogeneous and unreliable, prone to produce technical
problems and false results [6,7]. The use of gene-specific primers
flanking specific locations enables to obtain information on the
potential mechanisms, and the extension of the deletions. These
studies also highlighted the improved value of including gene-
specific markers in the minimal set of markers for the analysis [8].
On the other hand, complete deletions of specific AZF regions
have been associated with different spermatogenic scenarios such
as: AZFa to Sertoli cell-only syndrome, AZFb/AZFbc to
spermatogenic arrest with interruption in meiosis I, and AZFc to
hypospermatogenesis leading to severe oligozoospermia and
azoospermia. Interestingly, microdeletions of either the entire
AZFa or AZFb regions heralds a poor prognosis for sperm
retrieval from testicular sperm extraction (TESE) or testicular
biopsy, whereas half of the men with complete AZFc deletion have
successful sperm retrieval [1]. Nonetheless, the AZFc region is the
most frequently deleted in patients with non-obstructive azoosper-
mia or severe oligozoospermia, attaining about 70% of all the
cases. From previous observations, neither it is possible to infer the
phenotype from the classic genetic testing for the AZFc region nor
to identify the genes essential for normal spermatogenesis that this
sub-region harbors [5]. Hence, in order to provide a strategy that
would accelerate the identification of spermatogenesis candidate
genes, our goal was to develop a method that would allow the
screening of the main AZFc genes in large number of patients with
non-obstructive idiopathic azoospermia or severe oligozoospermia.
In terms of gene content, the AZFc region contains 11 families
of transcription units expressed only in the testis. Five of them code
for proteins, four are pseudogenes, and two have open reading
PLOS ONE | www.plosone.org 1 May 2014 | Volume 9 | Issue 5 | e97227
frames [9]. Namely, the deleted in azoospermia (DAZ) gene family is
expressed in spermatogonia and encodes a RNA-binding protein
important for spermatogenesis. Four copies of this gene (DAZ1,
DAZ2, DAZ3 and DAZ4) are located in AZFc [9,10,11]. The
chromodomain protein Y (CDY) gene family encodes a protein
containing a chromodomain and a histone acetyltransferase
catalytic domain located in the nucleus of late spermatids where
histone hyperacetylation takes place. The human Y chromosome
has two identical copies of this gene within the AZFc region
(CDY1A and CDY1B) and a pair of closely related genes in the
palindrome P5 (CDY2A and CDY2B) [6,12]. The testis-specific basic
protein Y 2 (BPY2) gene is expressed specifically in testis and its
protein product is involved in male germ cell development and
male infertility. Three nearly identical copies of this gene exist on
Y chromosome [13]. The PTPBL-related gene on Y (PRY) is expressed
specifically in testis and encodes a protein with similarity to protein
tyrosine phosphatase, non-receptor type 13. Two nearly identical
copies of this gene exist on the Y chromosome [14]. Golgi
autoantigen, golgi subfamily a, 2-like, Y-linked (GOLGA2LY) and
chondroitin sulfate proteoglycan 4 pseudogene 1, Y-linked (CSPG4P1Y)
families of transcription units have significant open reading frames,
are expressed only in testis and have predicted protein products.
Both have 2 copies located in P1 palindrome [9].
The previous are the main protein-coding genes located in the
AZFc region that are potentially related to spermatogenic failure,
although the specific contribution to spermatogenesis of each of
the individual genes is still not fully understood. Aiming to clarify
the implication of the main candidate genes in spermatogenic
failure, we selected these genes for a deeper understanding of how
Y chromosome microdeletions, and specifically the deletion of
AZFc-located genes, affect normal spermatogenesis. Herein we
designed a one-step multiplex PCR reaction for the identification
of the complete absence of six AZFc genes. The developed method
allows a rapid, simple, low-cost, high-throughput screening for
deletions of the main AZFc genes in patients with non-obstructive
idiopathic azoospermia.
Results
Design of the multiplex Real Time PCR/HRM method
As a first approach in order to develop a multiplex Real Time
PCR (rtPCR) system with High Resolution Melting analysis
(HRM) for AZFc gene screening we designed primers for the
specific amplification of all the copies of six AZFc genes. The
following genes were selected on the basis of their location in the
AZFc region of the Y chromosome, testis-only expression and
confirmed or predicted protein codification: DAZ, CDY, BPY2,
PRY, GOLGA2LY and CSGP4LY. Furthermore, SRY was selected as
internal amplification control, and AMELxy as internal and
specificity control. These primers were combined to establish
one single 8-plex reaction. High peak discrimination was achieved
by selecting amplification products with different predicted
melting temperature (Tm) values for each peak.
As a first step, we amplified normal undeleted male samples as
well as female samples attaining high amplification levels for all the
selected genes in male samples, while no amplification (except for
AMELxy) was observed in female samples (Figure 1). This optimal
condition was achieved by increasing the annealing temperature of
the PCR to 62uC. In order to confirm the specificity of the
amplification, all PCR products were sequenced and aligned to the
GeneBanks reference sequence, matching the genes of interest.
Performance of the method to detect specific gene
deletions
We tested control samples with AZFa, AZFb, AZFbc and AZFc
deletions in order to characterize the ability of the system to
identify the specific deletion of the genes located in these regions.
Deleted samples were previously analyzed by a modified for Real
Time EAA protocol in order to detect classical AZF microdele-
tions [15] and then undeleted samples were further analyzed for
partial AZFc microdeletions by means of STSs analysis, including
sY142, sY1191, sY1197, sY1201, sY1206, sY1261 and sY1291
markers [9,16]. As expected, inferred from the GenBanks Y
chromosome reference sequence, the AZFa-deleted sample
evidenced no deletion of the analyzed genes, conversely to
AZFb-deleted that showed lack of amplification for PRY gene,
AZFc-deleted no amplification of BPY2, DAZ, GOLGA2LY and
CSGP4LY genes, and AZFbc-deleted no amplification of PRY,
BPY2, DAZ, GOLGA2LY and CSGP4LY genes. Only those samples
with complete AZFabc deletion were negative for all the genes,
while positive for AMEL and SRY amplification controls
(Figure 2). When HRM data analysis was performed with Rotor
Gene software, which allows the automatic identification of the
peaks in the derivative (dF/dT) plot, the assignment of the sample
to a specific genotype was enabled.
Furthermore, we analyzed samples typified with Y chromosome
STSs markers routinely employed to identify gr/gr, b1/b3 and
b2/b3 partial AZFc microdeletions [16]. As expected, no peak loss
was observed as a consequence of the remaining gene copies.
Although no diagnosis of partial AZFc deletions could be
performed by this technique, a variation of peak height was
observed in partially deleted samples, most likely due to the
decrease of the remaining gene copy number. For example, in b2/
b3 deleted samples an inversion of peak height was observed for
BPY2, CSGP4LY and GOLGA2LY genes, which are located within
the deleted region (Figure 3). The same effect was observed in
samples with an AZFb deletion, where a decrease in peak height
for CDY, BPY2 and DAZ was observed as a consequence of gene
copy reduction.
Performance of three different intercalating dyes for
multiplex HRM
As the amplification was tested with three intercalating dyes,
namely SYBR Green I, EvaGreen and SYTO 9, it was possible to
compare their performance in multiplex amplification and HRM
peak discrimination. At first, the 8-plex reaction was set up with
SYTO 9 achieving high sensitivity, optimal melting peak
resolution and correlation between predicted and real Tm. When
the same reaction was reproduced with SYBR Green I, sensitivity
was compromised obtaining about 30% less fluorescence than with
SYTO 9 and peak loss was observed (Figure S1; green). Likewise,
when the reaction was performed with EvaGreen, a shift in the
predicted melting peaks towards higher temperatures was
observed (Figure S1; blue). Moreover, both tested commercial
kits are more expensive and require more DNA and primer input,
in contrast to SYTO 9 that allowed a fast setup of the multiplex
reaction with minimal costs. Therefore, we designed a standard
homemade PCR master mix with a universal intercalating dye as
SYTO 9 and regular desalted primers, plus DNA and primer
concentrations used have been reduced to a minimum without
losing sensitivity.
Robustness and sensitivity
To test the performance of the multiplex for robustness
regarding peak strength and separability, we analyzed 10 different
AZFc Genes Screening by Real Time PCR
PLOS ONE | www.plosone.org 2 May 2014 | Volume 9 | Issue 5 | e97227
Figure 1. High Resolution Melting derivative (dF/dT) profile for male and female samples. The figure shows each of the peaks for every
amplified gene in the male sample (blue) and only AMELxy peak in the female sample (red).
doi:10.1371/journal.pone.0097227.g001
Figure 2. High Resolution Melting derivative (dF/dT) profile for deleted and undeleted samples. The figure shows AZFa-deleted (orange)
and undeleted (red) samples with no gene deletions, AZFb-deleted sample with lack of amplification only of PRY gene (green), AZFc-deleted with no
amplification of BPY2, DAZ, GOLGA2LY and CSGP4LY genes (violet), AZFbc-deleted with no amplification of PRY, BPY2, DAZ, GOLGA2LY and CSGP4LY
genes (blue), and AZFabc with the sole amplification of AMEL and SRY genes (yellow), as evidenced by the corresponding missing peaks.
doi:10.1371/journal.pone.0097227.g002
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genomic DNA samples from males without AZFc deletions.
Regardless the origin of the sample, the melting peaks from every
sample were present and could be clearly distinguished. Further-
more, robustness was tested by a blind assay performed by a
different co-worker in which 5 undeleted controls and three
samples from AZFc deleted patients (b2/b4) were analyzed. In
agreement with the corresponding deleted region, the AZFc
deleted samples were correctly identified as missing BPY2, DAZ,
GOLGA2LY and CSGP4LY genes (data not shown).
The sensitivity of the system was evaluated by using genomic
DNA from an undeleted control. We performed the PCR reaction
with two-fold dilutions of the control sample ranging 20–
0.312 ng/mL. The individual melting peaks could be accurately
identified at concentrations bellow 10 ng/mL, despite that no
linear correlation between DNA concentration and signal strength
was evidenced. It is worth to notice that despite the complexity of
the multiplex reaction, all samples extracted by semi-automated
methods (usually ranging from 1 to 10 ng/mL) could be easily
analyzed, even avoiding previous quantification.
Portability of the method to a 96-well block based
system
As the multiplex system was established on a rotary with moving
hot air-based heating system Real Time PCR equipment (Rotor
Gene 6000), it was worthy to check portability of the method to a
different equipment. Hence, the reaction was also tested on a 96-
well block based system (StepOne Plus, Life Technologies, USA).
The latest is based on a heating block with LED based 4-color
optical detection. The multiplex reaction was reproduced exactly
as it was set up for Rotor Gene with the unique modification of the
melting curve stage following the manufacturers indications. We
also obtained an optimal peak separability, although the analysis
with StepOne Plus software was only qualitative due to the
limitation of the software to assign multiple melting peaks,
hampering the simultaneous analysis of all the genes in a high
number of samples (Figure 4).
Clinical validation of the method
The validation of the method was performed by analyzing 140
samples from patients consulting for infertility (screening group),
and 90 samples from azoospermic patients that were candidates
for testicular biopsy (azoospermic group). In the screening group,
only one patient with a complete AZFc or b2/b4 deletion showed
the absence of DAZ, GOLGA2LY, CSGP4LY and BPY2 genes. In the
azoospermic group, those with complete deletions of either or both
AZFb or AZFc regions were lacking the genes located in these
regions, namely DAZ, GOLGA2LY, CSGP4LY and BPY2 in AFZc,
plus PRY in AZFb. One sample with a complete AZFabc deletion
showed the absence of all the analyzed genes. All the samples with
gene deletions were azoospermic or severely oligozoospermic, and
none of the samples with sperm count above 56106/mL
evidenced any gene deletion.
Discussion
The characterization of spermatogenesis candidate genes may
lead to improvements in the diagnosis and treatment of male
patients suffering from infertility. Several methods for the
identification of the genes involved in Y chromosome microdele-
tions have been developed, although the majority did not allowed
large population screening. Herein we propose an 8-plex Real
Time PCR method with High Resolution Melting analysis for the
main AZFc candidate genes. The reaction was designed for the
specific amplification of every copy of six AZFc genes. The genes
Figure 3. High Resolution Melting derivative (dF/dT) profile for undeleted and b2/b3 deleted samples. The figure shows each of the
peaks for every amplified gene for undeleted (red) and b2/b3 deleted (blue) samples. In BPY2, GOLGA2LY and CSGP4LY genes, an inversion of the
peak high ration is observed (noted by asterisks) as a consequence of the incomplete deletion of these genes.
doi:10.1371/journal.pone.0097227.g003
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were selected on the basis of their location in the AZFc region of
the Y chromosome, testis only expression, and confirmed or
predicted protein codification. Primer sequences and multiplex
primer combinations were selected to achieve high separation of
melting peaks improved by the use of SYTO 9 intercalating dye
attaining the identification of gene presence without downstream
post PCR analysis.
Several detection chemistries are available for melting curve
analysis by Real Time PCR. Oligonucleotide probes or modified/
labeled primers are commercially available; nevertheless non-
sequence specific DNA dyes are more cost effective and equally
applicable. Among the latest, SYBR Green I has been widely used
although it suffers from several drawbacks as PCR inhibition and
dye redistribution. Other alternatives are SYTO or EvaGreen
dyes, both can be used at saturating concentrations without
affecting PCR efficiency and enable higher resolution melting
curve analysis [17]. From our results we evidenced that in contrast
to SYBR Green I; EvaGreen and SYTO 9 showed higher
sensitivity and broader peak separability. SYBR Green I failed in
amplifying all the products, in agreement with previous studies
that showed that SYRB Green I selectively detect particular
amplicons in melting curve analysis [18]. In contrast, SYTO 9
correlated better between predicted and real melting peaks,
meanwhile EvaGreen showed a switch of melting peaks towards
higher temperatures, probably due to stabilizing interactions of the
dye with the DNA. From our experience, the prediction of the
amplicons melting temperatures was accurately achieved by means
of Oligo Calculator v3.26 software. Additionally, as high reaction
efficiencies and signal strength are achievable with these dyes,
DNA and primer concentrations have been reduced to a
minimum without losing sensitivity. The development of a
standard homemade PCR with a universal intercalating dye as
SYTO 9 and regular desalted primers allowed a fast setup of the
multiplex reaction.
Although the advantage of the Rotor Gene-based data analysis
was the automatic identification of individual melting peaks in a
multiplex HRM derivative (dF/dT) profile, the reaction was
successfully reproduced in a heating block-based Real Time PCR
Figure 4. High Resolution Melting derivative (dF/dT) profile for undeleted and deleted samples obtained with StepOne Plus
equipment. The figure shows AZFa-deleted (orange) and undeleted (red) samples with no deletions, female sample with only AMELxy peak
presence (pink), AZFb-deleted sample with lack of amplification only of PRY gene (green), AZFc-deleted with no amplification of BPY2, DAZ,
GOLGA2LY and CSGP4LY genes (violet), and AZFbc-deleted with no amplification of PRY, BPY2, DAZ, GOLGA2LY and CSGP4LY genes (blue), as
evidenced by the corresponding missing peaks.
doi:10.1371/journal.pone.0097227.g004
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system achieving an optimal detection of each melting peak. It
should be taken into account that some differences in signal
strength are likely due to differential absorption wavelengths of the
instruments.
In order to guarantee the result of the analysis, AMEL gene
amplification was included to detect the presence of both X and Y
chromosome AMEL genes. SRY gene was amplified in order to
identify the presence of the Y chromosome and as an internal
control of the reaction. Due to the presence of Y chromosome
homologue genes located on the X and autosomal chromosomes,
the importance of AMELxy amplification in addition to female
control analysis rely on discarding unspecific amplification of
autosomal or X homologues in Y chromosome deleted samples.
The designed protocol has a high level of specificity for the AZFc
genes in order to ensure that the presence of a peak is only due to
the presence of the gene of interest.
In addition, when amplification products were checked by 3%
agarose gel electrophoresis to verify product size, this technique
allowed the identification of several bands, although some of the
products were not resolved due to similar molecular weight.
Despite being a low cost technique, agarose gel electrophoresis of
multiplex PCR products is not suitable for distinguishing between
products of similar size; instead their melting temperatures can
successfully differentiate the same products.
Interestingly, in partial AZFc deleted samples, although no peak
loss was detected, inversion of peak height was observed in those
genes involved in the deletion. Even though it was not the aim of
the developed protocol it is also possible to qualitatively
characterize samples with partial AZFc deletion by analyzing
melting peak height within the same sample.
Not less important is the DNA input used to perform the PCR
reaction. Although DNA quantification was performed, the herein
described method is useful within a DNA input ranging from 1 to
10 ng (data not shown). This amount is effortless achieved using
the standardized DNA extraction method herein described, so
DNA quantification step could be avoided.
The still unclear genotype–phenotype relationship reflects the
current knowledge about the AZFc region. AZF regions include
various genes which function is still unknown. Y chromosome
microdeletions are generally assessed for diagnostic purposes using
a set of anonymous STSs that are frequently not specific for the
genes located in this region. Within the markers included in the
screening protocol suggested by the European Academy of
Andrology, the only gene-specific STS is located within the DAZ
gene [5]. Therefore, the general trend should be to study the Y
chromosome using gene-specific markers (complementary to
classical STSs markers). In this way, the diagnosis will be more
accurate, and the study of a greater number of infertile patients
with this protocol will probably allow us to better understand the
biology of spermatogenesis and to clarify the genotype–phenotype
relationships. In addition, excluding DAZ, RBMY, USP9Y and DBY
genes, little is known about the other genes mapping the AZF
regions. Only future studies will clarify if these are involved in
human spermatogenesis and male infertility, and if they should be
included in the screening protocol. Our protocol includes genes
that have not yet been widely studied as PRY, GOLGA2LY and
CSGP4LY genes. It is worthy to mention that many of the findings
made on this matter couldnt have been possible with the current
proposed commercial kits for the screening of Y microdeletions
and additional approaches should be included [19,20,21].
A similar and widely used approach for identification of AZFc
genes is the gene dosage by quantitative PCR [16] or capillary
electrophoresis [22]. Even though gene dosage analysis permits the
quantification of specific genes, and therefore also the identifica-
tion of complete absence of them, it should be performed in a
simplex reaction. The limitation of quantifying a single gene relays
on the unspecific bound of intercalating dyes to all amplification
products, therefore not distinguishing between different genes.
This limitation can be overcome by labeling each primer pair with
different fluorophores, increasing significantly the cost of the
analysis. On the contrary, the analysis of the HRM profile of a
multiplex reaction makes it possible to detect the lack of
amplification of individual genes in a background of other
positively amplifying genes. Furthermore it has been shown that
gene copy number reduction does not correlate with the observed
phenotype; high similarity within gene copies make it likely to
replace in function those genes lost by deletion. Therefore we
suggest that the identification of genes involved in spermatogenic
failure should be performed to detect complete absence of the
genes.
On the other hand, capillary electrophoresis has been also
widely used specially for relative quantification of DAZ and CDY
genes. In this case, an autosomal homologue is amplified in
parallel to the gene of interest and the peak height ratio between
the autosomal and Y gene is analyzed. This approach, although
useful, has two main disadvantages: the inherent need for the
amplification of a homologue to each gene of interest and the
higher cost of labeled primers and capillary electrophoresis
equipments and supplies. With this in mind, both gene dosage
by qPCR and capillary electrophoresis are less suitable techniques
for large population screening due to higher costs and lower
throughput.
Although this newly developed method does not aim to detect
gene conversion on the AZF region of the Y chromosome, it is
important to notice that this phenomena may lead to translocation
or modification of the copy number of the genes located in this
region [23]. Taking into account that is still not clear which of the
copies of these genes are involved in spermatogenesis, we
underscore the importance of analyzing the presence/absence of
all the copies. In those samples where at least one of the gene
copies is still remaining, as the melting peak is observed, further
analysis of sequence family variants (SFVs) of these genes is
suggested to identify which of the missing copies could be involved
in the patients’ phenotype. In order to perform this analysis there
are several protocols available aiming to identify single nucleotide
polymorphisms (SNPs) in DAZ and CDY genes that are able to
differentiate between copies of these genes [24,25].
As previously published by our group, it is possible to employ
the HRM analysis tool with intercalating dyes not only for simplex
but also for multiplex amplifications. In a previous work, we
developed a technique to simultaneously detect from three to five
SNPs by means of one single amplification [26]. With this
background, the analysis of several genes by multiplex amplifica-
tion with intercalating dyes was an approachable goal. To our
knowledge, this is the first work to analyze six spermatogenesis
candidate genes in a multiplex approach. By means of the herein
described protocol it is possible to analyze six genes in up to 72
samples in less than 2 hours, making it the ideal tool for screening
large number of patients with idiopathic infertility. The developed
method uses common reagents, available in any molecular biology
laboratory, instead of labeled commercial kits that not always
provide with additional information to the assay. This approach is
useful for screening patients with non-obstructive azoospermia or
severe oligozoospermia, additionally to classical AZF and partial
AZFc deletions, and to being further correlated with testicular
biopsies findings.
We consider our work to be of high relevance to researchers
focused either on molecular basis or clinical aspects, mainly
AZFc Genes Screening by Real Time PCR
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diagnosis, of spermatogenic failure. Additionally, the approach
described in our work, although targeted to spermatogenesis
genes, can be applied to other research fields were gene screening
is relevant.
Materials and Methods
DNA samples
We used DNA from blood samples or cell lines to set up the
reaction. Normal undeleted and AFZc-deleted (b2/b4, b2/b3 and
gr/gr) male samples were selected from routine AZF screening.
Control DNA for P5/proximal P1 or AZFb-deleted (NA18332),
P5/distalP1 or AZFbc-deleted (NA18333), and b1/b3-deleted
(NA20434) Y chromosomes was purchased from Coriell Cell
Repository (New Jersey, USA). Human male DNA from AZFa-
deleted patient (WHT2996) was a courtesy of Dr. David C. Page
from the Whitehead Institute for Biomedical Research (Cam-
bridge, USA) [27]. As a specificity control, female samples have
been amplified in parallel. Samples used for the clinical validation
of the method were obtained from patients concurring either to
the Laboratory of Male Infertility or to the Urology Department,
both from the Hospital de Clı´nicas ‘‘Jose de San Martı´n’’. All
sample donors signed an informed consent. The ethics committee
of the School of Pharmacy and Biochemistry of the University of
Buenos Aires has approved the present study; nevertheless all the
samples were treated anonymously. All investigation has been
conducted according to the principles of the Declaration of
Helsinki.
DNA extraction and quantification
DNA from blood samples spotted onto Whatman 3MM paper
was extracted by means of a semi-automated platform (Maxwell,
Promega, USA) using manufacturer’s reagents and protocols.
Quantification of extracted DNA was performed by means of Real
Time PCR using a commercial kit (Plexor HY, Promega, USA)
and a Rotor Gene 6000 Real Time PCR equipment (Corbett
Research, Australia).
Primer design
NCBI Y chromosome reference sequence was searched for the
genes of interest. Optimal primers were designed using Primer3
software (http://frodo.-wi.mit.edu/primer3) [28]. The predicted
amplification products were checked using UCSC Genome
Browser online software (http://genome.ucsc.edu/cgi-bin/
hgGateway) and primers amplifying all the copies of the gene of
interest were selected. In order to obtain broader divergence
between melting peaks, amplicons melting temperature (Tm) was
predicted using Oligo Calculator v3.26 (http://www.basic.
northwestern.edu/biotools/OligoCalc.html). Location of the se-
lected amplification fragments is shown in Figure 5a and 5b. All
amplified sequences are shown along the Y chromosome using the
NCBIs Sequence Viewer 2.26 software (http://tinyurl.com/
d7s5ztr).
Multiplex PCR conditions
Multiplex amplification was tested with three intercalating dyes
included in different multiplex reactions, namely SYTO 9, SYBR
Green I (Life Technologies, USA) and EvaGreen (Biotium, USA).
SYBR Green I was part of the Quantitec SYBR Green PCR kit
(QIAGEN, Germany) and EvaGreen of Mezcla Real (Biodynam-
ics, Argentina). Commercial kit protocols were performed as
suggested by the manufacturer. Meanwhile, the herein developed
protocol employing SYTO 9 as intercalating dye was performed as
follows. Multiplex PCR reaction was carried out in 25 mL final
volume containing 37.5 pmol SYTO 9, 2 units GoTaq DNA
Polymerase (Promega, USA), 56 Colorless GoTaq Reaction
Buffer (Promega, USA), 20 nmol 4 dNTPs mix (Promega, USA),
primers (Integrated DNA Technologies, USA) (as indicated in
Table 1) and 2 mL DNA template (with a concentration between
0.3125 and 10 ng/mL). A detailed protocol is described in Protocol
S1 (see Supporting Information). Primer sequences and concen-
trations used in all the reactions are listed in Table 1. The
reactions were performed in a Rotor Gene 6000 (Corbett Life
Science, Australia) and in a StepOne Plus (Life Technologies,
USA) Real Time PCR equipment. PCR cycling conditions were
the following: initial denaturation step at 95uC for 1 min followed
by 30 cycles of 94 uC 10 s/62 uC 30 s/72 uC 30 s. Following
amplification, a High Resolution Melting (HRM) analysis was
performed ranging from 74 uC to 91 uC at 0.2 uC/s for Rotor
Gene 6000. When using StepOne Plus, the melting curve stage
was set as follows: 95uC 15 s–60uC 1 min followed by a 0.3%
continuous ramp from 74 uC to 91 uC. Likewise, the cycling profile
has been modified when Hot Start polymerase was used, as with
Quantitec SYBR Green PCR kit.
Sequencing of the amplification products
For confirmation of the specificity of the amplification, all PCR
products were cleaned up using Illustra ExoStar Kit (GE
Healthcare, UK) and sequenced with both forward and reverse
primers using the Big Dye Terminator Cycle Sequencing kit v3.1
(Life Technologies, USA), according to the supplier’s protocol.
Purification of the sequences from residual dye terminators was
performed by Isopropyl alcohol 75%/Ethanol 70% precipitation.
Capillary Electrophoresis of the sequences was carried out in an
ABI3500 Genetic Analyzer (Life Technologies, USA). Electrophe-
rograms were visualized and edited with Sequencher v4.8 software
(Gene Codes Corporation, USA). The obtained sequences were
aligned with GeneBanks reference sequence.
Analysis of classical AZF microdeletions
Classical AZF microdeletions were analyzed by the EAA
protocol, modified for Real Time PCR [15]. Briefly, AZFa,
AZFb, AZFc and AMEL primers were used. The protocol was
adapted and setup for amplification with SYTO 9 as intercalating
dye. From the primer combinations described by Kozina et al. we
selected those from Setup 2 (AMELxy, sY255, sY127 and
G34990), with the exception of G34990 primer that, due to
unspecific amplification of a sequence located on the X
chromosome, was switched for sY85.
Analysis of partial AZFc microdeletions
Partial AZFc microdeletions were analyzed by plus/minus
amplification of validated Sequence Tagged Sites (STS) markers
located in the Y chromosome [9,16]. Briefly, markers sY142,
sY1197, sY1191, sY1291, sY1206, sY1201 and sY1261 have been
amplified. Amplification was performed in a multiplex reaction
with 12.5 mL Multiplex PCR Master Mix (QIAGEN, Germany),
5 pmol FAM-labeled M13 primer (FAM-TGTAAAACGACGGC-
CAGT), unlabeled primers (listed in Table S1) and 2 mL template
DNA (ranging 1–10 ng/mL) in a total volume of 25 mL. The
cycling conditions were the following: 15 minutes for Taq
polymerase activation at 95uC, 30 cycles of 95uC 30 sec, 60uC
30 sec and 72uC 30 sec, and 8 cycles of 95uC 30 sec, 53uC 30 sec
and 72uC 30 sec, followed by 30 minute extension at 72uC. All
PCR reactions were performed in a Verity Thermal Cycler (Life
Technologies, USA). PCR primers sequences have been designed
with M13 tails for product detection with M13 primers labeled
with FAM, as previously described [29]. PCR products resolution
AZFc Genes Screening by Real Time PCR
PLOS ONE | www.plosone.org 7 May 2014 | Volume 9 | Issue 5 | e97227
Figure 5. Scheme of the AZFc region with amplicon and gene copy locations, (a). The figure shows the organization of the amplicon
sequences on the AZFc region of the Y chromosome indicated with arrows and selected genes indicated with triangles. Complete and partial AZFc
deletions are shown below. Ampliconic sequences nomenclature is according to Kuroda-Kawaguchi et al (2001). Location of the amplification
products on the reference Y chromosome, (b). The location is based on Homo sapiens chromosome Y, GRCh37.p10 Primary Assembly (http://tinyurl.
com/d7s5ztr).
doi:10.1371/journal.pone.0097227.g005
Table 1. Primers used for the multiplex PCR amplification.
Gene Primer sequence
Primer
input Product size Predicted Tm Real Tm N6Copies
(59-39) (pmol) (bp) (6C) * (6C) ** detected
AMEL ATCAGAGCTTAAACTGGGAAGCTG 8 106/112 76.3/76.8 77.560.5 1 or 2
CCCTGGGCTCTGTAAAGAATAGTG 8
CDY TGGAGAGGTTCAGGCACATG 13.5 111 78 79.260.5 4
TCCAGCTCTTCACCAGGTTC 13.5
BPY2 GGCAAGGTTCCTCCTTATCC 9 115 80.4 80.460.5 3
CACTTTCGAGGTTGGAAGGA 9
PRY GCTGCCTCCTCTCATCTGTC 13.5 114 82.4 82.060.5 2
TGGAAACTTCATCCCAGAGG 13.5
CSGP4LY AGGCTGATGTTGGAGGATTG 9 154 82.6 83.460.5 2
TCATGCCAAGAAGACACCTG 9
SRY GCCACACACTCAAGAATGGA 15.6 124 83 84.760.5 1
CCAATGTTACCCGATTGTCC 15.6
GOLGA2LY AGCCTTTTCCTTGTGGAGGT 9 366 85.4 85.960.5 2
GTGGACTCTGAGCCTCTTGG 9
DAZ TCTGTGCCTGCCTCTCTGTA 15.5 121 86 87.460.5 4
GCCTTATCCTCGGTTTTCCT 15.5
* Melting temperature (Tm) was predicted using Oligo Calculator v3.26.
** Melting temperature obtained with the newly developed SYTO 9 protocol and amplification in Rotor Gene 6000.
doi:10.1371/journal.pone.0097227.t001
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and detection was performed with a 3500 Genetic Analyzer (Life
Technologies, USA) and the analysis of the results was performed
with GeneMapper ID-X v1.2 software (Life Technologies, USA).
Supporting Information
Figure S1 High Resolution Melting derivative (dF/dT)
profile testing the performance of SYTO 9, SYBR Green
I and EvaGreen. The figure shows the bin locations according
to standard amplification with SYTO 9 of an undeleted sample
(red). EvaGreen shows optimal amplification of all the genes but
with approximately 1uC shift in melting temperature (blue). SYBR
Green I shows lack of detection of BPY2 genes, shift in melting
temperature and imbalance in melting peak height within all the
genes (green). The comparison was performed in standard
amplification conditions and 10 ng of DNA input.
(TIF)
Protocol S1 Detailed SYTO 9 multiplex reaction proto-
col.
(DOC)
Table S1 Primers used for Y-STS amplification.
(DOC)
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